Centiva Capital’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,867
| Closed | -$432K | – | 1291 |
|
|
2025
Q1 | $432K | Sell |
2,867
-8,644
| -75% | -$1.3M | 0.01% | 734 |
|
|
2024
Q4 | $2.12M | Buy |
11,511
+4,246
| +58% | +$784K | 0.04% | 189 |
|
|
2024
Q3 | $1.43M | Buy |
+7,265
| New | +$1.43M | 0.03% | 336 |
|
|
2023
Q4 | – | Sell |
-5,768
| Closed | -$1.13M | – | 1326 |
|
|
2023
Q3 | $1.13M | Buy |
5,768
+3,964
| +220% | +$777K | 0.02% | 313 |
|
|
2023
Q2 | $379K | Buy |
+1,804
| New | +$379K | 0.01% | 640 |
|
|
2022
Q3 | – | Sell |
-1,909
| Closed | -$409K | – | 1031 |
|
|
2022
Q2 | $409K | Buy |
+1,909
| New | +$409K | 0.01% | 681 |
|
|
2021
Q4 | – | Sell |
-756
| Closed | -$312K | – | 825 |
|
|
2021
Q3 | $312K | Buy |
756
+5
| +0.7% | +$2.06K | 0.02% | 617 |
|
|
2021
Q2 | $277K | Buy |
+751
| New | +$277K | 0.01% | 777 |
|
|
2021
Q1 | – | Sell |
-968
| Closed | -$242K | – | 957 |
|
|
2020
Q4 | $242K | Buy |
+968
| New | +$242K | 0.01% | 547 |
|
|
2020
Q2 | – | Sell |
-6,230
| Closed | -$786K | – | 482 |
|
|
2020
Q1 | $786K | Buy |
6,230
+4,748
| +320% | +$599K | 0.04% | 131 |
|
|
2019
Q4 | $226K | Buy |
+1,482
| New | +$226K | 0.01% | 357 |
|